Peter Steven St, 10% Owner at Pacira Pharmaceuticals, Inc. (PCRX), bought 461,538 shares at $6.50 ($3.0M) on 2011-11-21, disclosed to the SEC on 2011-11-22.
Open-market purchase of $3.0M PCRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| PETX | SELL | 2018-09-21 | $909K | — | Filing → |
| PETX | SELL | 2018-07-30 | $50K | — | Filing → |
| PETX | SELL | 2018-05-01 | $58K | — | Filing → |